Genmab — Marts 2018
-
Pauly...Jeg mangler også mit.

-
PS: Jeg rykker lige vores deltidsmedarbejder i teknikken.
-

-
Tusinde tak for den Pauly.

-
Vi må formode,
at aktiviteten i DDB har noget med warants-aktier at gøre. -
Hej Peter12...Det var super arbejde. Kan du dele det igen?
-
-
God morgen.

-
god morgen. A bit surprised to see this Ofa study on "Pemphigus Vulgaris" set to 'completed' only now https://clinicaltrials.gov/ct2/show/NCT01920477?term=daratumumab+OR+ofatumumab+OR+tisotumab&lupd_s=03%2F06%2F2018&rank=1 while we were told 2 years ago already that it would be discontinued
http://ir.genmab.com/releasedetail.cfm?releaseid=959265
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind